U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

This week has eight scheduled IPOs with three billion-dollar deals coming from the biotech, diagnostics, software and solar equipment industries, among others. Here's a rundown. read more.....»»

U.S. IPO Weekly Recap: NASH Biotech Jumps 69% As Multi-Billion Dollar Companies Join The Pipeline.....»»

A string of multibillion-dollar pharmaceutical deals announced over the last week call attention to a record-setting year in which drugmakers and biotechs have spent $342 billion snapping up smaller companies to bolster their pipelines......»»

U.S. IPO Weekly Recap: Oncology Biotech Aprea Therapeutics Finishes On Top In 4-IPO Week.....»»

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

U.S. IPO Week Ahead: 2 Billion-Dollar Biotechs And A Bank.....»»

U.S. IPO Week Ahead: A Wave Of Biotechs And Billion-Dollar Valuations In 6-IPO Week.....»»

U.S. IPO Weekly Recap: Health And Tech Shine As Week"s 5 IPOs Close Friday Up 20% Or More.....»»

U.S. IPO Weekly Recap: All IPOs Up Or Flat In An 8-IPO Week Led By Pinterest And Zoom.....»»

Despite losing .....»»

U.S. IPO Weekly Recap: Growth IPOs Take The Lead In A 5-IPO Week.....»»

The Massachusetts biotech sector could be headed toward a record-breaking year for IPOs after two more local drugmakers filed to go public late last week. Neon Therapeutics, a Cambridge-based cancer drug startup, disclosed in a federal filing on Thursda.....»»

U.S. IPO Weekly Recap: 12 IPOs Price In Record-Setting Week, Month And Quarter.....»»

On Friday, the US Energy Information Administration released its weekly natural gas storage report, which stated that natural gas stocks increased by 78 billion cubic feet (bcf) for the week ending on June 29. On Friday, the US Energy Inform.....»»

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week.....»»

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NA.....»»

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. read more.....»»

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

U.S. IPO Weekly Recap: Billion-Dollar StoneCo IPO Pops 30% Despite Market Turmoil.....»»

U.S. IPO Weekly Recap: 2 Foreign IPOs Price During Short Thanksgiving Week.....»»